CD8A and neoplasm: Three 20x high-density fields were taken of each tumor section, and Arg1 (as a marker of M2 TAMs), CD86 (as a marker of M1 TAMs), and CD8 (CD8+ Tc) positivity was evaluated using AI trainable WEKA segmentation.